NCT00129805View on ClinicalTrials.gov

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,510

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Cerebral Infarction
Interventions
DRUG

MCI-9042

DRUG

Aspirin

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY